ASSOCIATIONS BETWEEN VASPIN RS2236242 GENE
POLYMORPHISM, WALKING TIME AND THE RISK
OF METABOLIC SYNDROME
Suliga E1, Kozieł D2, Cieśla E3, Rębak D2, Wawszczak M2,*,
Adamus-Białek W2, Naszydłowska E4, Piechowska A2, Głuszek S2
*Corresponding Author: Monika Wawszczak, MSc, Department of Surgery and Surgical Nursery with Genetics
and Research Laboratory, Institute of Medical Sciences, Jan Kochanowski University, al. IX Wieków
Kielc 19a, 25-516, Kielce, Poland. Tel: +48-413696978. E-mail: mwawszczak@ujk.edu.pl
page: 41
|
|
REFERENCES
1. Suliga E, Wawszczak M, Gluszek S. The roles of
vaspin, chemerin, and omentin in the determination
of metabolic syndrome. Med Studies. 2018; 34(2):
160-177.
2. Feng R, Li Y, Wang C, Luo C, Liu L. Higher vaspin
levels in subjects with obesity and type 2 diabetes
mellitus: A meta-analysis. Diabetes Res Clin Pract.
2014; 106(1): 88-94.
3. Auguet T, Quintero Y, Riesco D, Morancho B, Terra
X, Crescenti A, et al. New adipokines vaspin and
omentin. Circulating levels and gene expression in
adipose tissue from morbidly obese women. BMC
Med Genet. 2011; 12: 60.
4. Mahdirejei HA, Abadei SFR, Seidi AA, Eshaghei
Gorji N, Rahmani Kafshgari H, Ebrahim Pour M,
et al. Effects of an eight-week resistance training on
plasma vaspin concentrations, metabolic parameters
levels and physical fitness in patients with type 2
diabetes. Cell J. 2014; 16(3): 367-374.
5. Esteghamati A, Noshad S, Mousavizadeh M, Zandieh
A, Nakhjavani M. Association of vaspin with metabolic
syndrome: The pivotal role of insulin resistance.
Diabetes Metabol J. 2014; 38(2): 143-149.
6. Alnory A, Gad H, Hegazy G, Shaker O. The association
of vaspin rs2236242 and leptin rs7799039
polymorphism with metabolic syndrome in Egyptian
women. Turkish J Med Sci. 2016; 46(5):1335-1340.
7. Hashemi M, Rezaei H, Eskandari-Nasab E, Kaykhaei
MA, Zakeri Z, Taheri M. Association between
chemerin rs17173608 and vaspin rs2236242 gene
poly-morphisms and the metabolic syndrome, a preliminary
report. Gene. 2012; 510(2): 113-117.
8. Mehanna ET, Mesbah NM, Ghattas MH, Saleh
SM, Abo-Elmatty DM. Association of chemerin
Rs17173608 and vaspin Rs2236242 gene polymorphisms
with metabolic syndrome in Egyptian women.
Endocr Res. 2016; 41(1): 43-48.
9. Suliga E, Kozieł D, Cieśla E, Rębak D, Głuszek S.
Dietary patterns in relation to metabolic syndrome
among adults in Poland: A cross-sectional study. Nutrients.
2017; 9(12): E1366.
10. Alberti KGMM, Eckel RH, Grundy SM, Zimmet
PZ, Cleeman JI, Donato KA, et al. Harmonizing the
metabolic syndrome: A joint interim statement of
the International Diabetes Federation Task Force on
Epidemiology and Prevention; National Heart, Lung,
and Blood Institute; American Heart Association;
World Heart Federation; International Atherosclerosis
Society; and International Association for the
Study of Obesity. Circulation. 2009; 120(16):1640-
1645.
11. Kohan L, Zarei A, Fallahi S, Tabiee O. Association
between vaspin rs2236242 gene polymorphism and
polycystic ovary syndrome risk. Gene. 2014; 539(2):
209-212.
12. Abdel Ghany SM, Sayed AA, El-deek SEM, Elbadre
HM, Dahpy MA, Saleh MA, et al. Obesity risk prediction
among women of Upper Egypt: The impact
of serum vaspin and vaspin rs2236242 gene polymorphism.
Gene. 2017; 626(1): 140-148.
13. Kempf K, Rose B, Illig T, Rathmann W, Strassburger
K, Thorand B, et al. Vaspin (SERPINA12) genotypes
and risk of type 2 diabetes: Results from the MONICA/
KORA studies. Exp Clin Endocrinol Diabetes.
2008; 118(3): 184-189.
14. Kilpeläinen TO, Qi L, Brage S, Sharp SJ, Sone-stedt
E, Demerath E, et al. Physical activity attenuates the
influence of FTO variants on obesity risk: A metaanalysis
of 218,166 adults and 19,268 children. PLoS
Med. 2011; 8(11): e1001116.
15. Kilpeläinen TO, Franks PW. Gene-physical activity
interactions and their impact on diabetes. Diabetes
Phys Act. 2014; 60: 94-103.
16. Abdullah MS, Verweij N, Van Der Harst P. Associations
of combined genetic and lifestyle risks with
incident cardiovascular disease and diabetes in the
UK biobank study. JAMA Cardiol. 2018; 3(8): 693-
702.
17. Grundy SM, Cleeman JI, Daniels SR, Donato KA,
Eckel RH, Franklin BA, et al. Diagnosis and management
of the metabolic syndrome. Circulation. 2005;
112(17): 2735-2752.
18. Paley CA, Johnson MI. Abdominal obesity and metabolic
syndrome: exercise as medicine? BMC Sports
Sci Med Rehabil. 2018; 10: 7.
19. Brito EC, Lyssenko V, Renstrom F, Berglund G, Nilsson
PM, Groop L, et al. Previously associated type 2
diabetes variants may interact with physical activity
to modify the risk of impaired glucose regulation and
type 2 diabetes: A study of 16,003 Swedish adults.
Diabetes. 2009; 58(6): 1411-1418.
20. Graff M, Scott RA, Justice AE, Young KL, Feitosa
MF, Barata L, et al. Genome-wide physical activity
interactions in adiposity – A meta-analysis of 200,452
adults. PLoS Genet. 2017; 13(4): e1006528.
21. Hamer M, Chida Y. Walking and primary prevention:
A meta-analysis of prospective cohort studies. Br J
Sports Med. 2008; 42(4): 238-243. 22. Kato M, Goto A, Tanaka T, Sasaki S, Igata A, Noda
M. Effects of walking on medical cost: A quantitative
evaluation by simulation focusing on diabetes.
J Diabetes Invest. 2013; 4(6): 667-672.
23. Tajima M, Lee JS, Watanabe E, Park JS, Tsuchiya
R, Fukahori A, et al. Association between changes
in 12 lifestyle behaviors and the development of
metabolic syndrome during 1 year among workers
in the Tokyo Metropolitan area. Circ J. 2014; 78(5):
1152-1159.
24. Kim SH, Lee SH, Ahn KY, Lee DH, Suh YJ, Cho
SG, et al. Effect of lifestyle modification on serum
chemerin concentration and its association with insulin
sensitivity in overweight and obese adults with type
2 diabetes. Clin Endocrinol. 2014; 80(6): 825-833.
25. Zhang D, Liu X, Liu Y, Sun X, Wang B, Ren Y, et al.
Leisure-time physical activity and incident metabolic
syndrome: A systematic review and dose-response
meta-analysis of cohort studies. Metabolism. 2017;
75: 36-44.
|
|
|
|
 |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
|
